Published in Nat Rev Clin Oncol on February 09, 2010
Malignant melanoma in the elderly: different regional disease and poorer prognosis. J Cancer (2011) 1.06
Age as a prognostic factor in patients with localized melanoma and regional metastases. Ann Surg Oncol (2013) 0.90
Responses to immune checkpoint inhibitors in nonagenarians. Oncoimmunology (2016) 0.76
Increasing Incidence of Melanoma in the Elderly: An Epidemiological Study in Olmsted County, Minnesota. Mayo Clin Proc (2016) 0.75
Chemotherapy use in stage III colon cancer: a National Cancer Database analysis. Ther Adv Med Oncol (2015) 0.75
Clinicopathologic characteristics and management trends of cutaneous invasive and in situ melanoma in older patients: a retrospective analysis of the National Cancer Data Base. Ther Adv Med Oncol (2015) 0.75
Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials. J Geriatr Oncol (2012) 0.75
So You Can Teach Old Fibroblasts New Tricks. Cancer Discov (2016) 0.75
Implications of age and conditional survival estimates for patients with melanoma. Melanoma Res (2016) 0.75
Impact of age on the management of primary melanoma patients. Oncology (2013) 0.75
Skin Cancer Epidemics in the Elderly as An Emerging Issue in Geriatric Oncology. Aging Dis (2017) 0.75
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med (2006) 15.64
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Increasing burden of melanoma in the United States. J Invest Dermatol (2009) 4.43
Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst (2001) 4.26
Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst (2001) 2.73
Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol (2004) 2.42
A call for the development and implementation of a targeted national melanoma screening program. Arch Dermatol (2006) 2.29
Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol (2004) 2.18
Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl J Med (1988) 2.15
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Patterns of detection in patients with cutaneous melanoma. Cancer (2000) 1.97
The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer (2008) 1.93
Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol (1998) 1.92
Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 1.80
Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy. Ann Surg Oncol (2005) 1.76
Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions. J Am Acad Dermatol (2007) 1.74
Is physician detection associated with thinner melanomas? JAMA (1999) 1.66
The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer (2007) 1.64
Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol (2008) 1.60
Screening for skin cancer: recommendations and rationale. Am J Prev Med (2001) 1.56
Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer (2008) 1.49
Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France. Arch Dermatol (2008) 1.45
Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol (1994) 1.43
Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center. Cancer (2003) 1.38
Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States. J Clin Oncol (2009) 1.33
Who discovers melanoma? Patterns from a population-based survey. J Am Acad Dermatol (1992) 1.32
Early detection of thick melanomas in the United States: beware of the nodular subtype. Arch Dermatol (2005) 1.29
The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma. Cancer (2001) 1.25
Age-related lymphatic dysfunction in melanoma patients. Ann Surg Oncol (2009) 1.22
Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. Ann Oncol (2007) 1.14
Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol (2005) 1.12
Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics. Cancer (2002) 1.02
Mitotic rate in melanoma: a reexamination. Am J Clin Pathol (2007) 1.01
Relative survival in elderly European cancer patients: evidence for health care inequalities. The EUROCARE Working Group. Crit Rev Oncol Hematol (2000) 1.00
Thick melanoma: the challenge persists. Br J Dermatol (2005) 0.88
Detection of nodular and superficial spreading melanoma with tumour thickness < or = 2.0 mm--an interview study. Eur J Cancer Prev (2002) 0.85
Senile changes in human lymph nodes. Lymphat Res Biol (2008) 0.83
Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res (2004) 2.29
Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev (2009) 1.60
Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res (2006) 1.58
Axillary node interventions in breast cancer: a systematic review. JAMA (2013) 1.22
The training and certification of surgical oncologists globally. Ann Surg Oncol (2015) 1.16
The role of ultrasound-guided fine-needle aspiration of axillary nodes in the staging of breast cancer. Ann Surg Oncol (2007) 1.06
Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin Cancer Res (2005) 1.00
Why do surgeons consider leaving practice? J Am Coll Surg (2011) 0.99
Protocol for the examination of specimens from patients with melanoma of the skin. Arch Pathol Lab Med (2009) 0.97
African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women. J Clin Oncol (2009) 0.90
Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer. Clin Cancer Res (2013) 0.89
State of the Journal 2010: managing growth, extending our reach--now the official journal for the Society of Surgical Oncology and the American Society of Breast Surgeons. Ann Surg Oncol (2010) 0.79
Can a small nodal metastasis reliably alter intraoperative risk/benefit decision making in breast cancer surgery? Ann Surg Oncol (2007) 0.75
Pediatric melanoma. Pediatr Blood Cancer (2005) 0.75
Prediction of non-SN involvement in patients with SN isolated tumor cells or micrometastases. Breast Dis (2010) 0.75
Protocol for the examination of specimens from patients with melanoma of the skin. Arch Pathol Lab Med (2003) 0.75
Atypical acquired pediatric Horner syndrome. Arch Ophthalmol (2010) 0.75